Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

Effexor XR (venlafaxine) is an antidepressant that has been found to reduce hot flashes in women undergoing treatment for breast cancer. Because it works so well in breast cancer patients, researchers ...

Citalopram, a selective serotonin reuptake inhibitor, is an effective, well-tolerated agent for the management of hot flashes, a novel study published in the Journal of Clinical Oncology has ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

The treatment that works best is menopausal hormone therapy (MHT). Since your body stops making some hormones during perimenopause and menopause, taking them as medicine can help with symptoms. You ...

Hormone replacement therapy (HRT) should be offered as the first treatment to ease menopause symptoms such as hot flushes and night sweats, according to the latest advice from health watchdog NICE.

Bayer said its Elinzanetant drug, which targets some symptoms produced by endocrine therapy in women with breast cancer, met all primary and secondary endpoints in a study. The German pharmaceutical ...